210 related articles for article (PubMed ID: 11513907)
21. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
Kononets AS
Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
[TBL] [Abstract][Full Text] [Related]
23. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
Unsematham S; Kateruttanakul P
J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
[TBL] [Abstract][Full Text] [Related]
24. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
25. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
26. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis.
Abal AT; Jayakrishnan B; Parwer S; El Shamy A; Abahussain E; Sharma PN
Respir Med; 2005 Apr; 99(4):415-20. PubMed ID: 15763447
[TBL] [Abstract][Full Text] [Related]
27. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
[TBL] [Abstract][Full Text] [Related]
28. Factors that effect sputum culture conversion rate in hospitalized patients with pulmonary tuberculosis who were applied directly observation therapy and non-directly observation therapy.
Uzundağ Işeri A; Dulkar G; Selçuk Sönmez O; Yilmaz Aydin L; Yilmaz B
Tuberk Toraks; 2010; 58(1):44-52. PubMed ID: 20517728
[TBL] [Abstract][Full Text] [Related]
29. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
30. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis.
Shiraishi Y; Nakajima Y; Katsuragi N; Kurai M; Takahashi N
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):523-8. PubMed ID: 15457152
[TBL] [Abstract][Full Text] [Related]
31. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
[TBL] [Abstract][Full Text] [Related]
32. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration.
Lancet; 1996 Feb; 347(8998):358-62. PubMed ID: 8598701
[TBL] [Abstract][Full Text] [Related]
33. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
Il'iuna TIa; Zhangireev AA; Sidorenko OA
Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis in Europe: a problem of drug resistance or much more?
Carvalho AC; Migliori GB; Cirillo DM
Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
[TBL] [Abstract][Full Text] [Related]
35. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
36. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
[TBL] [Abstract][Full Text] [Related]
37. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
39. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.
Datta M; Radhamani MP; Selvaraj R; Paramasivan CN; Gopalan BN; Sudeendra CR; Prabhakar R
Tuber Lung Dis; 1993 Jun; 74(3):180-6. PubMed ID: 8369512
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
